Mibampator

DB12717InvestigationalSmall molecule

Mibampator has been used in trials studying the treatment of Alzheimer's Disease.

Chemical structure of Mibampator
Formula / weight
C21H30N2O4S2 · 438.6 g/mol (avg)
Code names
LY-451395

Resolves to

Compound
UNIIA9V5BW73UUCAS375345-95-2ChEMBLCHEMBL1277001PubChem9889366
Structure
InChIKeyULRDYYKSPCRXAJ-KRWDZBQOSA-NSMILESCC(C)S(=O)(=O)NC[C@H](C)C1=CC=C(C=C1)C1=CC=C(CCNS(C)(=O)=O)C=C1

What you can answer from here — as of February 21, 2021

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Mibampator, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In